{"id":3257,"date":"2025-03-18T14:46:15","date_gmt":"2025-03-18T11:46:15","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=3257"},"modified":"2025-11-03T20:25:21","modified_gmt":"2025-11-03T17:25:21","slug":"biophytis-bio101-therapy-for-sarcopenia-could-bring-hope-to-duchenne-muscular-dystrophy-patients","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/biophytis-bio101-therapy-for-sarcopenia-could-bring-hope-to-duchenne-muscular-dystrophy-patients\/","title":{"rendered":"Sarkopeni Tedavisinde Biophytis&#039; BIO101 Terapisi Duchenne Musk\u00fcler Distrofi Hastalar\u0131na Umut Getirebilir"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Faz 2 klinik \u00e7al\u0131\u015fmas\u0131 SARA-INT, sarkopeni ara\u015ft\u0131rmalar\u0131 i\u00e7in birincil referans dergisi olan Journal of Cachexia, Sarcopenia and Muscle&#039;da (JCSM) yay\u0131mland\u0131 ve ya\u015fa ba\u011fl\u0131 hastal\u0131klar i\u00e7in tedaviler geli\u015ftirme konusunda uzmanla\u015fm\u0131\u015f klinik a\u015famadaki bir biyoteknoloji \u015firketi olan Biophytis i\u00e7in d\u00fcnya pr\u00f6miyeri oldu.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">SARA INT Trail&#039;deki BIO101&#039;nin temel nitelikleri \u015funlard\u0131r:<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Umut Vaat Eden Etkinlik:<\/strong> BIO101 350 mg bid, \u00e7al\u0131\u015fman\u0131n birincil son noktas\u0131 olan 400 metrelik y\u00fcr\u00fcme testinde (400MWT) klinik olarak anlaml\u0131 bir iyile\u015fme g\u00f6stermektedir<\/li>\n\n\n\n<li><strong>M\u00fckemmel G\u00fcvenlik:<\/strong> T\u00fcm dozlarda, BIO101 \u00fcr\u00fcnle ilgili Ciddi Olumsuz Olay (AE) olmaks\u0131z\u0131n \u00e7ok iyi bir g\u00fcvenlik profili g\u00f6stermektedir<\/li>\n\n\n\n<li><strong>Y\u00fcksek riskli pop\u00fclasyonda daha y\u00fcksek etkinlik:<\/strong> Yava\u015f y\u00fcr\u00fcyenlerde ve sarkopenik obezite alt pop\u00fclasyonlar\u0131nda 400MWT y\u00fcr\u00fcy\u00fc\u015f h\u0131z\u0131nda plaseboya k\u0131yasla nominal olarak anlaml\u0131 tedavi etkisi<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">BIOPHYTIS Hakk\u0131nda<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Klinik a\u015famada bir biyoteknoloji i\u015fletmesi olan Biophytis SA, ya\u015fa ba\u011fl\u0131 hastal\u0131klar i\u00e7in ila\u00e7 adaylar\u0131 yaratmaya adanm\u0131\u015ft\u0131r. \u015eirketin ba\u015fl\u0131ca ila\u00e7 aday\u0131 olan BIO101 (20-hidroksiekdizon), solunum yolu hastal\u0131klar\u0131 (COVID-19, Faz 2-3 tamamland\u0131), metabolik bozukluklar (obezite, Faz 2&#039;ye ba\u015flanacak) ve kas hastal\u0131klar\u0131 (sarkopeni, Faz 3 ba\u015flamaya haz\u0131r ve Duchenne kas distrofisi, Faz 1-2 ba\u015flamaya haz\u0131r) i\u00e7in geli\u015ftirilmekte olan k\u00fc\u00e7\u00fck bir molek\u00fcld\u00fcr.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Devam\u0131n\u0131 oku<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne \u0130\u00e7in Klinik Ara\u015ft\u0131rmalar (T\u00fcm Ara\u015ft\u0131rmalar\u0131n Listesi)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Phase 2 clinical trial SARA-INT was published in the Journal of Cachexia, Sarcopenia and Muscle (JCSM), the primary reference journal for sarcopenia research, marking a world premiere for Biophytis, a clinical-stage biotechnology company that specializes in creating treatments for age-related diseases. Key BIO101 Attributes from the SARA INT Trail include: About BIOPHYTIS A clinical-stage [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3259,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[309,308,307,66,310],"class_list":["post-3257","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-bio101","tag-bio101-therapy","tag-biophytis","tag-duchenne-muscular-dystrophy","tag-sarcopenia"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/3257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=3257"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/3257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/3259"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=3257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=3257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=3257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}